HomeTRVI • NASDAQ
add
Trevi Therapeutics Inc
Previous close
$4.32
Day range
$4.04 - $4.30
Year range
$1.27 - $4.68
Market cap
357.97M USD
Avg Volume
3.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.09M | 55.74% |
Net income | -13.24M | -72.02% |
Net profit margin | — | — |
Earnings per share | -0.13 | -62.50% |
EBITDA | -14.05M | -55.95% |
Effective tax rate | 0.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.49M | -26.30% |
Total assets | 68.91M | -28.14% |
Total liabilities | 9.94M | 58.11% |
Total equity | 58.97M | — |
Shares outstanding | 76.87M | — |
Price to book | 5.54 | — |
Return on assets | -49.35% | — |
Return on capital | -55.27% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -13.24M | -72.02% |
Cash from operations | -9.56M | -31.28% |
Cash from investing | 7.67M | -57.36% |
Cash from financing | 4.98M | 229.67% |
Net change in cash | 3.09M | -74.71% |
Free cash flow | -4.77M | -1.88% |
About
Founded
2011
Headquarters
Website
Employees
27
